Gingival overgrowth (drug‑induced) - Causes, Treatment & When to See a Doctor

```html

What is Gingival overgrowth (drug‑induced)?

Gingival overgrowth, also called drug‑induced gingival hyperplasia, is an abnormal increase in the size of the gums (gingiva) caused primarily by certain medications. The tissue becomes firm, thick, and can extend far enough to cover part of the teeth, making oral hygiene difficult and affecting speech, chewing, and appearance.

The condition is not a disease itself but a side‑effect of drug therapy. It is most commonly linked to three drug classes: phenytoin (an anti‑seizure medication), calcineurin inhibitors (e.g., cyclosporine, tacrolimus) used in organ‑transplant patients, and certain calcium channel blockers (e.g., nifedipine, amlodipine) prescribed for hypertension. When the overgrowth is severe, it can lead to periodontal disease, tooth loss, and psychological distress.

Common Causes

While medication is the leading trigger, a few other factors can exacerbate or mimic drug‑induced gingival overgrowth. Below are the most frequently implicated agents and conditions:

• Phenytoin (Dilantin) – antiepileptic drug; accounts for up to 50 % of cases.
• Cyclosporine (Neoral, Sandimmune) – immunosuppressant for organ‑transplant recipients.
• Tacrolimus (Prograf) – another calcineurin inhibitor with similar risk.
• Calcium‑channel blockers – especially nifedipine, amlodipine, and diltiazem.
• Antiretroviral therapy – some protease inhibitors have been reported to cause gingival changes.
• Antidepressants – selective serotonin reuptake inhibitors (SSRIs) rarely produce mild overgrowth.
• Vitamin C deficiency (Scurvy) – leads to gingival swelling that can be confused with drug‑induced growth.
• Hereditary gingival fibromatosis – a rare genetic condition that may be unmasked by certain drugs.
• Poor oral hygiene – plaque accumulation intensifies the tissue response to the offending medication.
• Hormonal changes – pregnancy or puberty can aggravate the effect of a drug on gingival tissue.

Associated Symptoms

Gingival overgrowth rarely occurs in isolation. Patients often notice additional oral or systemic signs, including:

• Bleeding gums, especially after brushing or flossing.
• Swollen, firm tissue that feels “puffy” rather than inflamed.
• Difficulty fitting dentures or wearing orthodontic appliances.
• Altered speech (lisps) or a “muffled” sound when speaking.
• Bad breath (halitosis) due to trapped food particles.
• Redness, tenderness, or a “burning” sensation in the mouth.
• Visible pockets between the gum and teeth, increasing risk of periodontitis.
• Cosmetic concern or self‑consciousness about a “bloated” smile.

When to See a Doctor

Because gingival overgrowth can progress quickly and lead to permanent damage, seek professional care promptly if you notice any of the following:

• Gums that have enlarged noticeably within weeks to months of starting a new medication.
• Bleeding that does not stop after applying pressure for a few minutes.
• Pain, pus, or a foul odor suggesting infection.
• Difficulty chewing, swallowing, or speaking.
• Rapid tooth movement, loosening, or loss.
• Persistent bad breath despite regular brushing.
• Any sign of an allergic reaction to the medication (rash, swelling of the lips, difficulty breathing).

Diagnosis

Diagnosis is primarily clinical, supported by a focused medical and dental history.

1. Medical & Medication Review

The clinician will ask about:

• All current prescription, over‑the‑counter, and herbal products.
• Duration and dosage of the suspect drug.
• Any recent changes in medication or dosage.
• History of epilepsy, organ transplantation, hypertension, or other relevant conditions.

2. Oral Examination

• Visual inspection of the gingiva for color, texture, and extent of overgrowth.
• Probing depth measurement to assess periodontal health.
• Assessment of plaque index and oral hygiene status.

3. Radiographic Imaging

Periapical or panoramic X‑rays may be taken to rule out underlying bone loss, tooth root issues, or hidden periodontal disease.

4. Biopsy (rare)

If the appearance is atypical or malignancy cannot be excluded, a small gingival tissue sample may be sent for histopathology.

5. Laboratory Tests

• Complete blood count (CBC) and serum vitamin C to exclude scurvy.
• Renal and liver function panels if the implicated drug is metabolized hepatically or renally.

Treatment Options

Management usually involves a combination of medication adjustment, meticulous oral care, and, when needed, surgical intervention.

1. Review & Modification of Medication

• Switching drugs – If feasible, your physician may substitute phenytoin with another antiepileptic (e.g., levetiracetam) or replace nifedipine with a different antihypertensive.
• Dosage reduction – Lowering the dose can lessen tissue proliferation while maintaining therapeutic effect.
• Adjunctive therapy – Adding folic acid (5 mg daily) has shown modest benefit in patients on phenytoin.

2. Intensive Oral Hygiene

• Brush twice daily with a soft‑bristled toothbrush and fluoride toothpaste.
• Floss or use interdental brushes to remove plaque from under the overgrowth.
• Consider an antimicrobial mouth rinse (e.g., chlorhexidine 0.12 %) for 2‑4 weeks.
• Professional dental cleanings every 3–4 weeks during the active phase.

3. Pharmacologic Measures

• Topical tetracycline or metronidazole – May reduce inflammation and bacterial load.
• Systemic folic acid supplementation – 5 mg daily for 4–6 weeks can help, especially in phenytoin‑related cases.

4. Surgical Management

When gingival tissue does not regress after drug adjustment and oral hygiene, surgery is considered.

• Scalpel gingivectomy – Traditional technique to excise excess tissue.
• Laser gingivectomy – CO₂ or diode lasers provide precise removal with reduced bleeding.
• Electrosurgery – Useful for small, localized overgrowths.
• Post‑operative care includes regular cleaning, pain control, and monitoring for recurrence.

5. Maintenance Phase

Even after successful treatment, recurrence is common if the triggering drug is continued. Lifelong periodontal maintenance visits (every 3–6 months) are essential.

Prevention Tips

While you may not be able to stop a necessary medication, you can minimize risk:

• Inform every prescriber that you are on a gingival‑overgrowth‑prone drug.
• Maintain excellent oral hygiene from the moment therapy starts.
• Schedule an initial dental check‑up within the first month of beginning the medication.
• Ask your doctor about the lowest effective drug dose.
• Use a soft‑bristled toothbrush and gentle brushing technique to avoid trauma.
• Consider daily rinses with chlorhexidine for the first 2–3 months of therapy.
• Stay hydrated; dry mouth can increase plaque accumulation.
• Take supplemental folic acid if you are on phenytoin (after discussing with your physician).
• Report any gum changes to your dentist or physician immediately.

Emergency Warning Signs

Key Takeaways

Drug‑induced gingival overgrowth is a manageable but potentially serious side effect of several common medications. Early recognition, collaboration between physicians and dental professionals, and diligent oral hygiene are the cornerstones of successful treatment. Never stop or alter a prescribed medication without consulting your healthcare provider, but do advocate for regular dental monitoring whenever you start a high‑risk drug.

References:

• Mayo Clinic. “Gingival hyperplasia.” Accessed March 2024.
• National Institutes of Health (NIH). “Phenytoin‑induced gingival overgrowth.” PubMed, 2022.
• Cleveland Clinic. “Medication‑induced gum overgrowth.” Updated 2023.
• World Health Organization. “Oral health guidelines.” 2021.
• American Academy of Periodontology. “Management of drug‑induced gingival overgrowth.” 2022.

```